Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2003
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0651759B1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
12/09/2003US6660852 Probe for diagnosing infectious diseases
12/09/2003US6660845 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
12/09/2003US6660490 Nucleotide seqences coding enzymatic polypeptide for use in the treatment of cardiovascular disorders
12/09/2003US6660484 Spectral changes in biopolymer
12/09/2003US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer
12/09/2003CA2051217C Process for the chemical synthesis of oligonucleotides
12/09/2003CA1341449C Poly-kringle plasminogen activator
12/04/2003WO2003100101A1 Methods and apparati using single polymer analysis
12/04/2003WO2003100099A1 Parallel stranded duplexes of deoxyribonucleic acid and methods of use
12/04/2003WO2003100082A2 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003WO2003100076A2 Pna probes, probe sets, method and kits pertaining to the determination of listeria
12/04/2003WO2003100032A2 Dwarfism genes and dwarf plants
12/04/2003WO2003100022A2 Methods and dna constructs for high yield production of polypeptides
12/04/2003WO2003100021A2 Methods and dna constructs for high yield production of polypeptides
12/04/2003WO2003100020A2 Methods and constructs for high yield expression of clostripain
12/04/2003WO2003100003A2 Isolated polynucleotides and methods of promoting a morphology in a fungus
12/04/2003WO2003100001A2 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/04/2003WO2003099998A2 Gene expression profiling of adult soft tissue sarcoma
12/04/2003WO2003099840A1 Oligonucleotides having modified nucleoside units
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099410A1 Process for chromatographic separation of nucleosides
12/04/2003WO2003099228A2 Compositions and processes for inhibiting gene expression using polynucleotides
12/04/2003WO2003099219A2 Bryostatins, bryopyrans and polyketides: compositions and methods
12/04/2003WO2003099215A2 Antisense modulation of glucocorticoid receptor expression
12/04/2003WO2003099209A2 Compositions and methods for screening and identifying anti-hcv agents
12/04/2003WO2003099204A2 Antisense modulation of inhibitor-kappa b kinase-beta expression
12/04/2003WO2003089897A3 Diagnosis and treatment of vascular disease
12/04/2003WO2003078626A3 A building block capable of transferring a functional entity
12/04/2003WO2003072727A3 EGFRvIII SPECIFIC MONOCLONAL ANTIBODY AND EGFRvIII RIBOZYMES AND USE TO DETECT, TREAT OR PREVENT EGFRvIII ASSOCIATED CANCER
12/04/2003WO2003062452A3 Methods for the integrated synthesis and purification of oligonucleotides
12/04/2003WO2003054223A3 Tripartite molecular beacons
12/04/2003WO2003054158A3 Rapidly maturing fluorescent proteins and methods for using the same
12/04/2003WO2003049671A3 Functionalized materials and libraries thereof
12/04/2003WO2003048338A3 Nucleic acid injected into hepatic vein lumen and delivered to primate liver
12/04/2003WO2003046134A3 Expression of polypeptides in rod outer segment membranes
12/04/2003WO2003039523A3 OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
12/04/2003WO2003032920A3 Oligonucleotide modulation of cell adhesion
12/04/2003WO2003028537A3 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
12/04/2003WO2003020901A3 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2003016561A3 Method for the production of cna
12/04/2003WO2003012120A3 Lp354 mammalian secreted protein
12/04/2003WO2003006625A3 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
12/04/2003WO2003002746A3 Perv screening method and use thereof
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002097126A3 Method for detecting gram-positive bacteria having a high gc content
12/04/2003WO2002064827A3 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
12/04/2003WO2002036808A8 Compositions and methods relating to prostate specific genes and proteins
12/04/2003US20030226177 Dwarfism genes and dwarf plants
12/04/2003US20030226171 Insect resistant plants and methods for making same
12/04/2003US20030226155 Modified transferrin-antibody fusion proteins
12/04/2003US20030225257 Comprises nucleotide sequences coding enzymatic polypeptides for use as drug screening, diagnostic and therapeutic tools; cosmetics; nutriceuticals
12/04/2003US20030225253 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/04/2003US20030225247 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
12/04/2003US20030225246 Novel human 7TM proteins and polynucleotides encoding the same
12/04/2003US20030225016 Chimeric immunomodulatory compounds and methods of using the same - III
12/04/2003US20030225009 28 human secreted proteins
12/04/2003US20030224976 Compositions, methods and kits relating to behab and primary CNS tumors
12/04/2003US20030224517 Comprises oligonucleotides which inhibit secretase activity on amyloid precursor proteins (APP) for treating alzheimer's and neurodegenerative diseases
12/04/2003US20030224501 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
12/04/2003US20030224498 Comprises nucleotide sequences coding serpin domains for diagnosis and treatment of metabolic and infectious disorders; enzyme inhibitors; cosmetic or nutriceutical; drug screening
12/04/2003US20030224483 Control of gene expression in eukaryotic cells
12/04/2003US20030224463 Using aberrant nucleotide sequence repair to diagnose and determine cancer predisposition
12/04/2003US20030224461 Nucleic acids, proteins, and antibodies
12/04/2003US20030224419 Data analysis and display system for ligation-based DNA sequencing
12/04/2003US20030224389 Concurrently separating double and single stranded polynucleotide sequences present in mixture via absorption of nucleic acids to mineral support; in vitro transcription
12/04/2003US20030224382 Measuring concentration of two or more nucleic acid molecules in target cell for use in diagnosing and treating cancer, autoimmune, infectious, aging, developmental, proliferative and neurological disorders
12/04/2003US20030224377 Novel LNA compositions and uses thereof
12/04/2003US20030224359 Tmleveling methods
12/04/2003US20030224358 Comprises nucleotide sequences coding membrane protein for use as anticarcinogenic/antitumor/antiinflammatory agent
12/04/2003US20030224353 Uncharged oligomers having a targeting base sequence that is substantially complementary to a viral target sequence which spans the AUG start site of the first open reading frame of the viral genome
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224055 Compositions and processes for inhibiting gene expression using polynucleotides
12/04/2003US20030224012 Identifying a BASB033 polypeptide or an antibody that is immunospecific for such polypeptide, present with in a biological sample form the animal suspected having meningococcus induced infections and meningitis
12/04/2003US20030223992 G-protein coupled receptor ligands and methods
12/04/2003US20030223976 Control sequences of the human corin gene
12/04/2003US20030223973 Discloses the protease stratum corneum chymotrytic enzyme (SCCE) is specifically over-expressed in ovarian and other malignancies. A number of SCCE peptides can induce immune responses to SCCE, thereby demonstrating the potential of
12/04/2003CA2694419A1 Isolated polynucleotides and methods of promoting a morphology in a fungus
12/04/2003CA2525976A1 Modulation of ptp1b signal transduction by rna interference
12/04/2003CA2487557A1 Modulators and inhibitors of fibroblast growth factor receptor 5 polypeptides and gene expression thereof
12/04/2003CA2486193A1 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003CA2485837A1 Methods and dna constructs for high yield production of polypeptides
12/04/2003CA2485835A1 Methods and dna constructs for high yield production of polypeptides
12/04/2003CA2485829A1 Methods and constructs for high yield expression of clostripain
12/04/2003CA2485648A1 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/04/2003CA2484010A1 Pna probes, probe sets, methods and kits pertaining to the determination of listeria
12/03/2003EP1366197A2 Methods and compositions for amplification of rna sequences
12/03/2003EP1366192A2 Direct multiplex characterization of genomic dna
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366057A2 Reagents for oligonucleotide cleavage and deprotection
12/03/2003EP1365774A2 Use of zwitterionic polysaccharides for the specific modulation of immune processes
12/03/2003EP1365726A2 Method for evaluating therapeutic efficacy
12/03/2003EP0973785B1 Trans-platinum compound, and diagnostic kit
12/03/2003EP0765393B1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
12/03/2003EP0724644B1 Dna encoding 1,3-beta-d glucan synthase subunits
12/03/2003CN1460023A Polymer-modified bioactive sythetic chemokines, and method for their mfg. and use
12/03/2003CN1459503A Jiulian agglutinin protein and its code sequence
12/03/2003CN1459458A Testes spermatogenous cell die related gene
12/03/2003CN1459456A Nucleic acid deodour method